Hedge Fund - Harvey Partners
Harvard Bioscience Inc (HBIO)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $1,238,125 | 0.14% | 2,187,500 | $1.28 |
| 2 | 2024 - Q4 (2024-12-31) | $5,661,130 | 0.62% | 2,683,000 | $2.30 |
| 3 | 2024 - Q3 (2024-09-30) | $7,303,350 | 0.83% | 2,715,000 | $2.95 |
| 4 | 2024 - Q2 (2024-06-30) | $7,288,875 | 0.87% | 2,557,500 | $3.51 |
| 5 | 2024 - Q1 (2024-03-31) | $10,843,800 | 1.14% | 2,557,500 | $4.50 |
| 6 | 2023 - Q4 (2023-12-31) | $13,682,625 | 1.55% | 2,557,500 | $4.51 |
| 7 | 2023 - Q3 (2023-09-30) | $10,997,250 | 1.39% | 2,557,500 | $4.61 |
| 8 | 2023 - Q2 (2023-06-30) | $13,856,760 | 1.69% | 2,524,000 | $5.49 |
| 9 | 2023 - Q1 (2023-03-31) | $11,393,340 | 1.4% | 2,712,700 | $2.97 |
| 10 | 2022 - Q4 (2022-12-31) | $8,064,855 | 1.02% | 2,911,500 | $2.46 |
| 11 | 2022 - Q3 (2022-09-30) | $7,453,000 | 1.09% | 2,911,300 | $3.31 |
| 12 | 2022 - Q2 (2022-06-30) | $10,314,000 | 2.26% | 2,865,000 | $4.51 |
| 13 | 2022 - Q1 (2022-03-31) | $13,823,000 | 3.4% | 2,226,000 | $5.92 |
| 14 | 2021 - Q4 (2021-12-31) | $8,918,000 | 3.62% | 1,265,000 | $7.11 |
| 15 | 2021 - Q3 (2021-09-30) | $7,120,000 | 5.32% | 1,020,036 | $7.96 |
| 16 | 2021 - Q2 (2021-06-30) | $9,163,000 | 6.34% | 1,100,000 | $7.07 |
| 17 | 2021 - Q1 (2021-03-31) | $6,006,000 | 4.14% | 1,100,000 | $4.86 |
| 18 | 2020 - Q4 (2020-12-31) | $4,260,000 | 2.95% | 993,000 | $3.73 |
| 19 | 2020 - Q3 (2020-09-30) | $2,378,000 | 3.08% | 790,000 | $3.36 |
| 20 | 2020 - Q2 (2020-06-30) | $2,559,000 | 3.08% | 825,500 | $2.69 |
| 21 | 2020 - Q1 (2020-03-31) | $3,776,000 | 3.41% | 1,708,466 | $2.71 |
| 22 | 2019 - Q4 (2019-12-31) | $3,086,000 | 1.75% | 1,011,701 | $2.88 |
| 23 | 2019 - Q3 (2019-09-30) | $2,283,000 | 1.64% | 742,500 | $2.49 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
1319.0000:1000.0000 on 2013-11-04